Department of Neurology, University of Muenster, Albert-Schweitzer-Str. 33, Muenster, Germany.
J Neurol. 2010 Nov;257(11):1864-8. doi: 10.1007/s00415-010-5624-2. Epub 2010 Jun 18.
Inherited neuropathies caused by mutations of the major structural protein of peripheral myelin, myelin protein zero (MPZ), contribute to 5% of all cases of Charcot-Marie-Tooth disease (CMT). They can be divided into an early-onset neuropathy with symptoms prior to the stage of walking, and a late-onset neuropathy with symptoms at the age of 40 and older. In this study, five patients with four novel MPZ mutations were identified by molecular genetic testing which presented as mild and late-onset neuropathies. We recommend testing for MPZ mutations in patients with a late-onset neuropathy, as late-onset inherited neuropathies might be more frequent than previously thought.
由周围髓鞘主要结构蛋白髓鞘蛋白零(MPZ)突变引起的遗传性神经病占所有 Ch arcot-Marie-Tooth 病(CMT)病例的 5%。它们可分为在行走阶段之前出现症状的早发性神经病和在 40 岁及以上出现症状的迟发性神经病。在这项研究中,通过分子遗传学检测鉴定了 5 名具有 4 种新型 MPZ 突变的患者,其表现为轻度和迟发性神经病。我们建议对迟发性神经病患者进行 MPZ 突变检测,因为迟发性遗传性神经病可能比以前认为的更为常见。